Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study
Mayo Clinic proceedings, 2026
BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia
Current medical research and opinion, 2026;:1-10
Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis
BMC ophthalmology, 2026
Tirzepatide versus conventional GLP-1 receptor agonists for treatment simplification in type 2 diabetes mellitus: a real-world study
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review
Cureus, 2026;18(6):c457
Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
Journal of health economics and outcomes research, 2026;13(1):288-296
Discovery of DDO-4279 as a PP5 degrader for the treatment of obesity
RSC medicinal chemistry, 2026
Case Report: Latent autoimmune diabetes in two young female patients successfully treated with oral semaglutide and basal insulin
Frontiers in endocrinology, 2026;17:1833794
Differential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus
Current issues in molecular biology, 2026;48(7)
Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis
Cureus, 2026;18(6):e111786
GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms
Skin appendage disorders, 2026
[Effect of a combined physiotherapeutic approach on changes in functional parameters after endovitreal surgery of rhegmatogenous retinal detachment with a favorable anatomical outcome]
Vestnik oftalmologii;142(3):29-37
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026;201:119717
Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial
Schizophrenia research, 2026;296:19-28
Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026
Engineered circular RNA compatible with complete nucleoside modification and rolling circle translation through a Cap-independent translation enhancer
Nature biomedical engineering, 2026
Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction
Communications medicine, 2026
Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes
Communications medicine, 2026
[Insulin intoxications caused by falsified semaglutide]
Nederlands tijdschrift voor geneeskunde, 2026;170
Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study
Obesity pillars, 2026;19:100292